首页> Urologic oncology> Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: Results of a phase II study

Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: Results of a phase II study

导出原文传递

翻译打印收藏纠错

第一作者： Friedlander,T.W.

作者： Friedlander,T.W. ^[1] ; Weinberg,V.K. ; Small,E.J. ; Sharib,J. ; Harzstark,A.L. ; Lin,A.M. ; Fong,L. ; Ryan,C.J.

作者单位： Urologic Oncology Program, Department of Medicine, Helen Diller Family Comprehensive Cancer Center ^[1]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Urologic oncology

2012年30卷4期

408-414页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Urologic oncology

2012年30卷4期

408-414页

检索历史清除

Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: Results of a phase II study

Urologic oncology

相似文献

同项目论文

Urologic oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: Results of a phase II study

Urologic oncology

相似文献

同项目论文

Urologic oncology

相关期刊

检索历史清除